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Myonuclear transcription is responsive to
mechanical load and DNA content but uncoupled
from cell size during hypertrophy
Tyler J. Kirbya,b, Rooshil M. Patela, Timothy S. McClintocka, Esther E. Dupont-Versteegdenb,c,
Charlotte A. Petersonb,c, and John J. McCarthya,b,*
a

Department of Physiology, College of Medicine, bCenter for Muscle Biology, and cDepartment of Rehabilitation
Sciences, College of Health Sciences, University of Kentucky, Lexington, KT 40536

ABSTRACT Myofibers increase size and DNA content in response to a hypertrophic stimulus,
thus providing a physiological model with which to study how these factors affect global
transcription. Using 5-ethynyl uridine (EU) to metabolically label nascent RNA, we measured
a sevenfold increase in myofiber transcription during early hypertrophy before a change in
cell size and DNA content. The typical increase in myofiber DNA content observed at the
later stage of hypertrophy was associated with a significant decrease in the percentage of
EU-positive myonuclei; however, when DNA content was held constant by preventing myonuclear accretion via satellite cell depletion, both the number of transcriptionally active myonuclei and the amount of RNA generated by each myonucleus increased. During late hypertrophy, transcription did not scale with cell size, as smaller myofibers (<1000 μm2)
demonstrated the highest transcriptional activity. Finally, transcription was primarily responsible for changes in the expression of genes known to regulate myofiber size. These findings
show that resident myonuclei possess a significant reserve capacity to up-regulate transcription during hypertrophy and that myofiber transcription is responsive to DNA content but
uncoupled from cell size during hypertrophy.
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INTRODUCTION
Global transcription is tightly coupled with cell size (Zhurinsky et al.,
2010; Kempe et al., 2015; Padovan-Merhar et al., 2015). By adjusting the level of transcription, protein and RNA content are kept proportionate to cell size, ensuring optimal conditions for biochemical
reactions (Zhurinsky et al., 2010; Marguerat and Bahler, 2012). Unlike
RNA and protein, DNA content does not appear to scale with cell
size (Schmidt and Schibler, 1995). For example, hepatocytes and
neurons can become exceptionally large while still harboring two
copies of the genome; however, transcriptional output per unit of
DNA is increased to maintain mRNA concentration levels in such
large cells (Sato et al., 1994; Miettinen et al., 2014). Consistent with
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the idea that transcriptional output is sensitive to cell size and DNA
content, Padovan-Merhar et al. (2015) reported that cells are able to
decrease transcriptional burst frequency or increase transcription
burst magnitude to accommodate an increase in gene dosage or
cytosolic volume, respectively.
Skeletal muscle cells (myofibers) are unique among the cells of
the body in that each myofiber is a large syncytium containing hundreds of nuclei. In response to a hypertrophic stimulus, such as mechanical load, myofibers are able to significantly increase both size
and total RNA content (von Walden et al., 2012). The increase in
RNA content during myofiber hypertrophy is believed to be primarily driven by transcription, but it is unknown how such an increase in
global transcription is coordinated among myonuclei. Does transcriptional output increase proportionally across all myonuclei, or is
a subset of myonuclei transcriptionally active? Under resting conditions, transcription of specific mRNAs has been shown to occur in a
pulsatile manner within a subset of myonuclei, but whether this behavior reflects global transcriptional output remains to be determined (Newlands et al., 1998).
It is well established that hypertrophic growth induced by mechanical overload results in myonuclear accretion via satellite cell

Supplemental Material can be found at:
http://www.molbiolcell.org/content/suppl/2016/01/11/mbc.E15-08-0585v1.DC1
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fusion (McCarthy et al., 2011), yet it is unknown how transcriptional
output is affected by such an increase in myofiber DNA content.
One hypothesis proposes that myonuclear accretion is necessary
during hypertrophy to increase the transcriptional capacity of the
cell; however, myonuclear accretion does not appear to be absolutely required to support myofiber growth despite the observation
that DNA content does limit cell size (Blaauw et al., 2009; McCarthy
et al., 2011; Lee et al., 2012). We reported that total RNA content
and myofiber growth persist in the absence of myonuclear accretion, although we did not investigate how this affected global transcription (McCarthy et al., 2011).
In the present study, we used skeletal muscle hypertrophy as a
model system to determine how changes in DNA content and cell
size affect nascent transcription. Unlike previous studies, skeletal
muscle hypertrophy provides a nonpathological, in vivo model to
study how these factors affect global transcription (Zhurinsky et al.,
2010; Padovan-Merhar et al., 2015). Using 5-ethynyl uridine (EU) to
label newly synthesized RNA, we tested the hypotheses that during
muscle hypertrophy, nascent transcription 1) scales with myofiber
size and 2) would be lower per myonucleus with increased DNA
content. The results of the study demonstrate for the first time that
during skeletal muscle hypertrophy, myofibers are almost entirely
responsible for the significant increase in transcriptional output and
that, like other cell types, global transcription of myofibers was sensitive to a change in DNA content; however, transcriptional output
of myofibers did not scale with cell size, such that small myofibers
had the highest level of transcription. Although the underlying
mechanism for this uncoupling awaits further investigation, it may
reflect the higher oxidative metabolism of small fibers, thereby providing a greater metabolic capacity to better support increased
transcription.

RESULTS
Myogenic cells are the predominant source of nascent
transcription during muscle hypertrophy
Synergist ablation surgery was used to place mechanical overload
on skeletal muscle to induce hypertrophy, and global transcription
was assessed via incorporation of a uridine analogue (EU; Figure
1A). Mechanical overload of the plantaris muscle induced by synergist ablation (SA) resulted in a progressive increase in muscle mass
(Figure 1B) and myofiber cross-sectional area (Supplemental Figure
S1), which was accompanied by a significant, ∼2.5-fold increase in
total RNA per unit of tissue by day 7 (Figure 1C). Newly synthesized
RNA that had incorporated the EU nucleotide (EU-RNA) was visualized on muscle cross-sections, in combination with a laminin antibody to define the basement membrane surrounding each myofiber. After a 5-h pulse, EU-RNA was only detectable within nuclei,
which allowed for quantification of the percentage of skeletal muscle nuclei that were stained positive for EU-RNA (Figure 1D). Regardless of the time point, the vast majority (92–96%) of EU-positive
nuclei were located within the laminin border, thus belonging to
myogenic cells, that is, both myofiber and satellite cells (Figure 1E).
Double labeling of EU-RNA and the satellite cell–specific transcription factor Pax7 revealed minimal colocalization (Supplemental
Figure S2, related to Figure 1, C and D), indicating that myonuclei
are the predominate source of newly synthesized RNA in response
to mechanical overload.

Nascent transcription is highly enriched for muscle-specific
transcripts
The limited amount of EU-RNA labeling observed in nonmuscle
cells suggests that the rate of transcription was significantly less
Volume 27 March 1, 2016

than in myofibers, and, as a result, the intensity of labeling in nonmuscle cell nuclei was below the level required for fluorescent detection. Therefore, in a complementary approach to the microscopic analysis, we affinity purified the labeled nascent RNA and
performed quantitative PCR (qPCR) for cell type–specific transcripts and compared the expression profile to the profile obtained from the total RNA pool. If a cell type–specific transcript is
enriched in the nascent RNA pool, independent of differences in
transcript half-life, this would suggest that a greater proportion of
the nascent RNA is being produced by that cell type. We focused
on the major cells types that comprise skeletal muscle, including
myofibers, satellite cells, fibroblasts, endothelial cells, and macrophages. The EU labeling microscopy data showed that the proportion of labeling between myogenic and nonmyogenic cells did not
change during hypertrophic growth; therefore we focused qPCR
analysis on sham-control muscle samples. To control for the potential effect of transcript half-life, we selected cell type–specific transcripts that had comparable half-lives and characterized them as
either short lived or intermediate lived. As would be expected, the
nascent RNA pool was enriched for short-lived transcripts. The
only cell type–specific mRNA that was significantly enriched was
Murf1, the myofiber-specific transcript (Figure 1F), which remained
enriched across the hypertrophic time course (Supplemental
Figure S3, A–C, related to Figure 1F). In agreement with the shortlived transcripts, the intermediate-lived, myofiber-specific transcript Sgcg was significantly enriched (Figure 1G). The intermediate-lived, macrophage-specific transcript Csf2ra also showed
significant enrichment compared with Col3a1 and CD31, which
are fibroblast and endothelial markers, respectively (Figure 1G).
EU-RNA has been readily detected in nonmyogenic cell types in
other tissues, using the same pulse duration (Supplemental Figure
S4; Jao and Salic, 2008). Thus it seems unlikely that nonmyogenic
cells are not taking up the EU analogue. Instead, the inability to detect EU-labeled RNA in nonmyogenic cells suggests that the level of
transcription of nascent RNA was significantly lower under resting
conditions and during periods of hypertrophic growth. Collectively
both microscopic and gene expression analyses demonstrate that
metabolic labeling of nascent RNA in skeletal muscle was enriched
for RNA produced within the myofiber. Thus we used this enrichment
to assess how nascent transcription was affected by changes in DNA
content and myofiber size in response to a hypertrophic stimulus.

Increased nascent transcription in individual myonuclei
during hypertrophy
To determine whether the increase in total RNA content observed
with hypertrophy is due to an increase in the percentage of transcriptionally active myonuclei, we quantified the number of EU-positive
myonuclei relative to total myonuclei during mechanical overload–
induced hypertrophy (Figure 2A). In comparison to sham (58%), there
was no significant difference at SA3 and SA7, with ∼65 and 45% of
myonuclei labeled, respectively; however, at SA14, the percentage
of EU-positive myonuclei decreased by 43%, with only 32% of myonuclei being positive for EU-RNA (Figure 2B). Given that the increase
in total RNA content observed at SA7 did not appear to be caused
by an increase in the number of active myonuclei, we next quantified
transcriptional output by determining the amount of EU-RNA at each
time point using integrated fluorescence density. There was a significant, 7.4-fold increase in the amount of EU-RNA at SA3 compared
with sham, with no difference at SA7 and SA14 (Figure 2C).
To determine whether the increase in EU-RNA at SA3 was
the result of increased gene transcription in myogenic nuclei, we
quantified the amount of H3K9ac, a histone modification indicative
Transcription during hypertrophy
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FIGURE 1: Mechanical overload results in a progressive increase in plantaris muscle mass and
RNA content derived primarily from myogenic cells. Animals were subjected to synergist
ablation (SA) for 3, 7, or 14 d and injected with 2 mg of EU 5 h before being killed. This
paradigm enriched for nascent RNA (EU-RNA) labeling within myogenic cells. (A) Schematic for
labeling of nascent RNA after mechanical overload. (B) Plantaris muscle mass normalized to the
body weight of the animal. *Significant difference between SA7 and SA14 compared with Sham.
†
Significant difference between SA14 relative to SA3. (C) RNA abundance within the muscle
tissue normalized to tissue weight. *Significant difference compared with Sham. (D) Red arrows
indicate myogenic nuclei identified by their location within the laminin stain surrounding the
myofiber. White arrow indicates a nonmyogenic nucleus outside the laminin stain of the
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of active gene transcription (Figure 3A and
Supplemental Figure S5) (Karmodiya et al.,
2012; Wang et al., 2008). The percentage of
myonuclei immunoreactive for H3K9ac did
not change across the time course (Figure
3B); however, the intensity of H3K9ac immunofluorescence was significantly increased at SA3 and SA7, reflecting a global
increase in promoter activation (Figure 3C).
Because histone acetylation is short lived
(Barth and Imhof, 2010), these results indicate the increased transcription observed at
SA3 was due to higher transcriptional activity per myonucleus rather than more active
myonuclei.

We reported that the synergist ablation
model of hypertrophy induced a significant
increase in the number of myonuclei per
myofiber as the result of satellite cell fusion
(McCarthy et al., 2011). Thus perhaps the reduced percentage of EU-labeled myonuclei
observed at SA14 was the result of an increase in myofiber DNA content at this time
point. To assess the effect of DNA content
on transcription, we prevented myonuclear
accretion by the conditional depletion of satellite cells using the previously described
Pax7-DTA mouse strain (McCarthy et al.,
2011; schematic in Figure 4A). After tamoxifen administration, the satellite cell pool was
depleted by 90% (Supplemental Figure S6,
A and B, related to Figure 4), resulting in
these myofibers having 32% fewer myonuclei at SA14 than with vehicle-treated control
muscle (Supplemental Figure S6C, related to
Figure 4). The absence of nuclear fusion in
myofiber. Scale bar, 50 μm. (E) Quantification
of the percentage of either myogenic or
nonmyogenic nuclei that stain positive for
EU-RNA during mechanical overload of
skeletal muscle. *Significantly greater
percentage of EU-RNA–positive nuclei in
myogenic cells than in nonmyogenic cells.
(F) Enrichment for short-lived (∼4–6 h) cell
type–specific markers. Murf1 (myofiber) was
significantly enriched relative to Tcf4
(fibroblast cell), Tie2 (endothelial cell), Pax7
(satellite cell), and Emr1 (macrophage cell).
*Significantly greater enrichment than with
other cell-specific mRNAs. (G) Enrichment for
intermediate-lived (12–18 h) cell type–specific
markers. Scgc (myofiber) was significantly
enriched relative to Col3a1 (fibroblast cell),
CD31 (endothelial cell), and Csf2ra
(macrophage cell). *Significantly greater
enrichment than with all other markers.
†
Significant enrichment relative to Col3a1 and
CD31. For all analyses, p < 0.05 and n = 5–7
at each time point. All data are presented as
mean ± SEM.
Molecular Biology of the Cell
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FIGURE 2: Increased transcriptional demand during mechanical overload is met by elevated transcription within each
myonucleus. EU-RNA within myonuclei was quantified on muscle cross-sections at various time points after mechanical
overload. (A) Representative images of EU-RNA labeling during mechanical overload. Scale bar, 50 μm.
(B) Quantification of the percentage of myonuclei that stained positive for EU-RNA during mechanical overload.
*Significantly higher percentage of EU-RNA–positive nuclei at Sham and SA3 time points relative to SA14 (p < 0.05 and
n = 5 or 6 mice per time point). (C) Quantification of the integrated density of EU-RNA labeling per myofiber during
mechanical overload. *Significantly higher integrated density of EU-RNA at the SA3 time point relative to all other time
points (p < 0.05 and n = 5 or 6 mice per time point). Data are presented as mean ± SEM.

satellite cell–depleted muscle resulted in a significantly greater percentage of myonuclei staining positive for EU-RNA at SA14 than with
vehicle-treated muscle, such that it was comparable to the percentage of EU-labeled myonuclei observed at SA3 in wild-type mice
(compare Figure 4, B and C, to Figure 2B). The amount of EU-RNA
per myofiber was also significantly higher in tamoxifen-treated muscle at SA14 than with vehicle-treated muscle (Figure 4D). Thus resident myonuclei were sensitive to myofiber DNA content and able to
maintain elevated levels of nascent transcription in the absence of
myonuclear accretion to presumably meet the transcriptional demand required for hypertrophy.

Nascent transcription is uncoupled from cell size during
hypertrophy
Given that global transcription is tightly coupled to cell size, we
sought to determine the relationship between myofiber size and
nascent transcription. We focused our analysis on SA3 samples
because it was the only time point that showed a significant increase in EU-RNA per myofiber (Figure 2, A and C). Under sham
conditions, there was no significant difference in the amount of
EU-RNA produced in myofibers of different sizes (Figure 5, A and
B). Although nascent transcription was increased in all myofibers
at SA3 relative to sham, the smallest myofibers (<1000 μm2)
showed the highest amount of EU-RNA (Figure 5, C and D). FurVolume 27 March 1, 2016

thermore, a greater proportion of myonuclei in these small fibers
stained positive for EU-RNA than with sham (Supplemental Figure
S7, A and B, related to Figure 5). However, by SA7 and SA14,
there was a rightward shift toward a greater proportion of larger
fibers containing an EU-RNA label (Supplemental Figure S7, C
and D), demonstrating a similar distribution to the sham condition. The rightward shift at SA14 was also observed in the Pax7DTA strain (Supplemental Figure S8, A and B), indicating that nuclear accretion was not responsible for the higher transcription in
larger fibers at SA14. Fibers were binned based on their size to
determine how fiber cross-sectional area changed during overload-induced hypertrophy (Figure 5E). Based on the relative frequency of fiber cross-sectional area, it appeared that the most
pronounced growth occurred in small myofibers (<1000 μm2), with
a large decrease in the frequency of these fibers by SA7. These
findings show that, unlike other cell types, transcriptional output is
uncoupled from cell size in myofibers during hypertrophic growth.

Labeling of nascent RNA reveals potential
posttranscriptional regulation of gene expression
The in vivo imaging results showed that nascent transcription was
dramatically up-regulated during the early stage of muscle hypertrophy. We wanted to take advantage of the myofiber enrichment
of nascent RNA to quantify the expression of genes known to have
Transcription during hypertrophy
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FIGURE 3: Increased global transcription is associated with increased H3K9ac labeling intensity in myonuclei. H3K9ac
staining within myonuclei was quantified on muscle cross-sections at various time points after mechanical overload.
Arrows indicate H3K9ac-positive myonuclei. (A) Representative images for H3K9ac staining in skeletal muscle crosssections. Scale bar, 50 μm. (B) Quantification of the percentage of myonuclei that stained positive for H3K9ac during
mechanical overload. There was no significant change in the percentage of H3K9ac staining (p < 0.05 and n = 3 or 4
mice per time point). (C) Quantification of the integrated density of H3K9ac labeling per myonucleus during mechanical
overload. *Significantly higher integrated density of H3K9ac labeling at the SA3 and SA7 time points relative to Sham
(p < 0.05 and n = 3 or 4 mice per time point). Data are presented as mean ± SEM.

a role in regulating global transcription and, secondarily, determine
whether changes in gene expression were the result of transcription and/or mRNA stability. Two well-characterized pathways that
are known to regulate muscle hypertrophy are the mammalian target of rapamycin complex 1 (mTORC1) and Wnt/β-catenin pathways (Armstrong et al., 2006; Goodman et al., 2011). Downstream
targets of these pathways have been shown to influence global
transcription, as well as ribosomal DNA transcription (Nader et al.,
2005; Iadevaia et al., 2012; Lin et al., 2012). Taking a candidate approach, we selected genes known to be regulated by these pathways and responsive (either up- or down-regulated) to mechanical
792 | T. J. Kirby et al.

overload–induced muscle hypertrophy; we measured by qPCR the
total RNA and nascent RNA expression levels of cMyc, Mstn,
Mafbx, and Igf1 to determine whether the change in expression
was regulated at the level of transcription and/or mRNA stability.
cMyc was significantly more abundant in both the total and nascent RNA fractions (∼4.1- and ∼3.8-fold, respectively) at SA3, indicating that transcription was the primary mechanism driving this increase (Figure 6, A and B). cMyc mRNA remained significantly
elevated at SA7 as the result of increased mRNA stability, given that
nascent RNA returned to baseline; cMyc mRNA at SA14 was no
different from sham, although mRNA stability remained significantly
Molecular Biology of the Cell
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FIGURE 4: Myonuclei modulate transcriptional output to accommodate nuclear accretion. Nuclear accretion was
inhibited by the specific and conditional depletion of satellite cells using the Pax7-DTA mouse strain. (A) Schematic.
(B) Representative images of EU-RNA intensity with (vehicle) or without (tamoxifen) myonuclear accretion. (C) Increased
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higher (Figure 6, A and B). Mstn expression was significantly decreased in both RNA fractions after mechanical overload, which initially (SA3) was caused by a decrease in transcription that at a later
time point (SA7) was the result of a decrease in mRNA stability
(Figure 6, C and D). Similarly, Mafbx mRNA was significantly decreased during mechanical overload as the result of a decrease in
transcription with no change in transcript stability (Figure 6, E and F).
Finally, Igf1 mRNA significantly increased in response to mechanical
overload, and this was due to an increase in transcription with no
apparent change in mRNA stability (Figure 6, G and H).
Given that the vast majority of cellular RNA is rRNA, it is likely
that the significant increase in EU-RNA observed at SA3 was rRNA.
Volume 27 March 1, 2016

Consistent with the microscopic analysis, pre-47S expression was
significantly higher at SA3 relative to all other time points (Figure 6I).
This finding indicated that ribosome biogenesis was up-regulated at
SA3, providing the basis for the significant increase in total RNA
content observed at SA7 and SA14 (Figure 1B).

DISCUSSION
Skeletal muscle myofibers comprise a multinucleated syncytium capable of readily increasing cellular volume and DNA content in response to a hypertrophic stimulus. The purpose of this study was to
determine how these factors influence nascent transcription during
hypertrophy, which was induced by mechanical overload. The major
Transcription during hypertrophy
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findings of the study are as follows: 1) myofibers are overwhelmingly the most transcriptionally active cell type in skeletal muscle at rest and during hypertrophy, 2) in
response to mechanical overload, resident
myonuclei demonstrate the intrinsic capacity to significantly up-regulate transcription
by greater than sevenfold, 3) when myofiber
DNA content is held constant during hypertrophy, transcription remains significantly
elevated for a prolonged period of time in
resident myonuclei, and 4) in contrast to
other cell types, in mechanically overloaded
muscle, transcription is highest in the smallest myofibers.
Whether myofibers partition global transcriptional output equally across all myonuclei within the syncytium or instead restrict
transcription to a subset of nuclei was unknown. Further, it was not known how the
partitioning of transcriptional output might
be altered in response to a hypertrophic
stimulus and what influence cell size and
DNA content may have on this process. A
previous study showed that myonuclear
transcription of a few select genes occurred
in pulses and that the proportion of active
myonuclei changed during postnatal growth
(Newlands et al., 1998). Taking a global approach, we show that nascent transcription is
heterogeneous across myonuclei at rest,
and, in response to mechanical overload,
transcription is significantly up-regulated but
only at the initial stage (SA3) of hypertrophy.
This up-regulation of transcription is the result of individual myonuclei increasing their
transcriptional output rather than simply increasing the proportion of transcriptionally
active myonuclei. Furthermore, this increase
in transcription cannot be explained by an
initial larger myonuclear domain, as smaller
fibers actually have a smaller myonuclear domain (van der Meer et al., 2011a,b). Although
the mechanisms regulating the increase
in myonuclear transcription remain to be
determined, increases in cytoplasmic volume were reported to increase the amplitude of transcriptional burst (Padovan-Merhar et al., 2015); however, we did not observe
a significant increase in myofiber size until
SA7. This finding indicates that myofibers
are able to dramatically increase global transcription, independent of detectable

Cross-seconal Area (µm2)
FIGURE 5: Increased global transcription preferentially occurs in small myofibers during
hypertrophic growth. Myofibers were binned based on their cross-sectional area to determine
the effect of cell size on EU-RNA integrated density levels. (A) Representative image of EU-RNA
labeling intensity under Sham conditions. Scale bar, 50 μm. (B) No significant difference in
EU-RNA per fiber with across cell size under sham conditions. (C) Representative image for
increased EU-RNA labeling in small myofibers at SA3. Yellow/red arrowhead indicates a
nucleus in a cell <1000 μm2, and green/red arrow indicates a nucleus in a cell >2000 μm2.
Note the difference in EU-RNA staining intensity in the fibers <1000 μm2. Scale bar, 50 μm.
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(D) Progressive decrease in EU-RNA
integrated density with increasing cell size.
*Significant difference between cell sizes
(n = 5 for each cell size bin). (E) Mechanical
overload results in a rightward shift in the
relative frequency of large fibers (>2000 μm2)
at SA7 (n = 5 or 6 mice per time point). All
data are presented as mean ± SEM.
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ability to increase their DNA content during
hypertrophy via the fusion of satellite cells
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historically been viewed as necessary during
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meet the global transcriptional demand required to support hypertrophic growth. Contrary to this idea, we showed previously that
myofibers can undergo robust growth when
DNA content is held constant after the depletion of satellite cells (McCarthy et al.,
2011). The results of the present study
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SA7
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FIGURE 6: Nascent RNA labeling reveals
altered stability of mRNAs involved in
regulating global transcription. Nascent RNA
was affinity purified from total RNA, and both
fractions were used to determine changes in
transcript levels and transcript stability in
response to mechanical overload. A decrease
in the nascent RNA:total RNA indicates
increased transcript stability, whereas an
increase in the nascent RNA:total RNA
indicates decreased transcript stability.
(A, B) cMyc. (A) cMyc shows increased
abundance during mechanical overload.
†
Significant increase within the respective
RNA fraction relative to Sham conditions.
(B) cMyc demonstrates increased transcript
stability at SA7 and SA14 relative to Sham.
*Significant difference from Sham. (C, D) Mstn.
(C) Mstn shows decreased expression during
mechanical overload. †Significant decrease
within the respective RNA fraction relative to
Sham conditions. (D) Mstn demonstrates
decreased transcript stability at SA7 relative
to Sham. *Significant difference from Sham.
(E, F) Mafbx. (E) Mafbx shows decreased
expression during mechanical overload.
†
Significant decrease within the respective
RNA fraction relative to Sham conditions.
(F) No significant change to Mafbx stability
during mechanical overload. (G) Igf1
expression after mechanical overload.
†
Significant increase within the respective
RNA fraction relative to Sham conditions
(p < 0.05 and n = 5 mice per time point).
(H) No significant change to Igf1 stability with
mechanical overload. (I) Nascent RNA is
enriched for rRNA pre-47S, which increased at
SA3 in response to mechanical overload.
†
Significant increase within the respective
RNA fraction relative to Sham conditions
(p < 0.05 and n = 5 mice per time point for all
genes). All data are presented as mean ± SEM.
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suggest that muscle is able to compensate for the loss of satellite cells
by maintaining a higher level of transcription in the existing myonuclei. How myonuclei are able to sustain an elevated level of transcription with a relatively lower DNA content remains to be determined,
but one possibility is increased transcriptional pulse frequency. Padovan-Merhar et al. (2015) reported that transcriptional pulse frequency
changed according to genomic content, such that higher DNA content caused a decrease in pulse frequency.
A somewhat surprising finding of the present study was the apparent disconnect between cell size and global transcription during
hypertrophy, with smaller myofibers showing the highest level of nascent transcription. A possible explanation for this finding may involve the metabolic phenotype of small myofibers, which is quite
different from that of the larger myofibers (Goodman et al., 2012;
Fry et al., 2014). Small fibers in the mouse plantaris muscle are classified as type IIa and have a high oxidative metabolic capacity due
to a high mitochondrial content. Given that global transcription is
highly dependent on cellular ATP levels and mitochondrial mass (das
Neves et al., 2010), type IIa myofibers may have a greater biosynthetic activity than larger, more glycolytic myofibers. This notion is
supported by the work of Goodman et al. (2012), who showed that
the rate of protein synthesis was highest in small, type IIa myofibers
during hypertrophy, with these fibers also undergoing the greatest
hypertrophy. It is likely that the disconnect between cell size and
transcription that we observed is not a unique property of skeletal
muscle but instead reflects a difference between cells under homeostatic conditions and cells undergoing hypertrophy. Alternatively, it
may be that multinucleated myofibers regulate global transcription
differently than mononucleated cells during hypertrophic growth.
In addition to investigating transcription dynamics, the labeling
of nascent RNA also provides the ability to determine whether
changes in gene expression are regulated at the level of transcription and/or mRNA stability. We focused on genes that have a known
role in regulating global transcription (cMyc) or skeletal muscle size
(Mstn, Murf1, and Igf1) and are responsive to changes in mechanical
load (Adams and Haddad, 1996; Yamaguchi et al., 2006; Chaillou
et al., 2014). In general, early (SA3) changes in mRNA abundance,
regardless of whether an mRNA was increased or decreased, were
primarily driven by transcription, whereas at later time points (SA7
and SA14), changes in mRNA stability made a greater contribution
to mRNA abundance. This finding, together with the fact that nascent transcription was highly myofiber specific, provides the foundation for a more comprehensive study aimed at developing regulatory networks based on shared mechanisms of regulation.
Together the findings of this study provide the first evidence describing the transcriptional response of myonuclei to a hypertrophic
stimulus. In particular, the evidence presented shows that, similar to
other cell types, the transcriptional output of resident myonuclei is
sensitive to changes in myofiber DNA content and that, unexpectedly, during hypertrophy the level of transcription does not scale
with cell size, suggesting that small myofibers require an unusually
high transcriptional output. Moreover, the results of this study
demonstrate that skeletal muscle hypertrophy provides a powerful
physiological model with which to better understand how changes
in DNA content and cell size affect global transcription.

MATERIALS AND METHODS
Mice
All animal procedures were conducted in accordance with institutional guidelines for the care and use of laboratory animals as approved by the Institutional Animal Care and Use Committee of the
University of Kentucky. For initial time course experiments, male and
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female C57BL/6J mice 4–6 mo of age (Jackson Laboratory, Bar
Harbor, ME) were housed in a temperature- and humidity-controlled
room and maintained on a 14:10 h light:dark cycle with food and
water ad libitum. For myonuclear accretion experiments, male and
female Pax7-DTA mice were used as previously described (McCarthy
et al., 2011; Fry et al., 2014; Lee et al., 2015). Briefly, these mice allow for the inducible and specific depletion of the primary stem cell
(satellite cell) in adult skeletal muscle after administration of tamoxifen. At 4 mo of age, Pax7-DTA mice were administered by intraperitoneal injection either vehicle (15% ethanol in sunflower seed oil) or
tamoxifen (2 mg/d) for 5 consecutive days, followed by a 2-wk washout period before synergist ablation surgery.
The mice were subjected to bilateral synergist ablation surgery
to induce hypertrophy of the plantaris muscle as previously described in detail (McCarthy and Esser, 2007). Briefly, after anesthetization with a mixture of 95% oxygen and 5% isoflurane gas, the soleus and the majority of the gastrocnemius muscles were surgically
excised, with particular attention made to ensure that the neural and
vascular supply remained intact and undamaged for the remaining
plantaris muscle. Sham surgery controls involved similar procedures
without gastrocnemius and soleus muscle excision. After recovery
from surgery, mice were anesthetized at the designated time point
by an intraperitoneal injection of ketamine (100 mg/kg) and xylazine
(10 mg/kg), and plantaris muscles were excised and weighed. Tissue
used for RNA was flash frozen in liquid nitrogen and stored at −80°C
until further use. Tissue used for microscopy was pinned to a cork
block at resting length, covered with a thin layer of Tissue Tek optimum cutting temperature (OCT) compound (Sakura Finetek, Torrance, CA), and then quickly frozen in liquid nitrogen–cooled isopentane and stored at −80°C until sectioning. For time-course
experiments, plantaris muscle was collected at 3, 7, and 14 d after
the surgery (SA3, SA7, and SA14, respectively; n = 5 per time point).
Control plantaris muscle (n = 5) was collected from mice subjected
to a sham synergist ablation surgery at each of the time points
(Sham). For nuclear accretion experiments, plantaris was collected
14 d after surgery (n = 6). After collection of the plantaris muscle, the
mice were killed by cervical dislocation under anesthesia.

Nascent RNA labeling
For nascent RNA visualization and expression experiments, mice
were given an intraperitoneal injection of 2 mg of EU (Jena Biosciences, Jena, Germany) suspended in sterile phosphate-buffered
saline 5 h before being killed. Five hours was chosen after it was
determined this pulse period allows for maximal visual detection of
nascent RNA within the nucleus in both sham and overloaded skeletal muscle (Supplemental Figure S9). EU is a uridine analogue that
is incorporated specifically into newly synthesized RNA (Jao and
Salic, 2008). Each EU molecule had been modified to contain an
alkyne group, which can then be used for detection with molecules
containing an azide group via copper-mediated “click” chemistry.

Histochemistry
Frozen tissue was sectioned (7 μm), air dried for ∼20 min, and then
immediately fixed in 4% paraformaldehyde. For EU-RNA detection,
sections were incubated in a solution containing Tris base (100 mM),
copper(II) sulfate (4 mM), biotin-conjugated azide (100 μm; Jena
Biosciences), and ascorbic acid (100 mM) for 30 min at room temperature and washed, and this procedure was repeated. Sections
were then incubated in Texas red–streptavidin (1:150; Vector Labs,
Burlingame, CA) for 60 min at room temperature. Sections were postfixed in 4% paraformaldehyde (PFA), blocked in 1% bovine serum
albumin (BSA) for 1 h, and then incubated with an anti-laminin
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antibody (1:100; Sigma-Aldrich, St. Louis, MO) overnight at 4°C. Sections were washed, and laminin immunoreactivity was visualized with
Alexa Fluor 488 goat anti-rabbit secondary (1:500; Invitrogen, Carlsbad, CA) and counterstained with 4′,6-diamidino-2-phenylindole
(DAPI). For histine 3 lysine 9 acetylation (H3K9ac), sections were air
dried for 1 h, fixed in 4% PFA, blocked using 1% BSA, and incubated
in primary antibody (1:1000; ab10812; Abcam, Cambridge, MA)
overnight 4°C using a 1:500 dilution in 1% BSA. H3K9ac was visualized using Alexa Fluor 594 chicken anti-rabbit secondary (1:500; Invitrogen). Sections were washed and reacted with laminin antibody
and DAPI as described.
For Pax7 detection, sections were fixed in 4% PFA, followed by
epitope retrieval using sodium citrate (10 mM, pH 6.5) at 92°C for
20 min. Endogenous peroxidase activity was blocked with 3% hydrogen peroxide in phosphate-buffered saline for 7 min, followed by an
additional blocking step with Mouse-on-Mouse Blocking Reagent
(Vector Laboratories). Incubation with Pax7 antibody (1:100; Developmental Studies Hybridoma Bank, Iowa City, IA) was followed by incubation with the biotin-conjugated secondary antibody (1:1000;
Jackson ImmunoResearch, West Grove, PA), and the signal was amplified using streptavidin–horseradish peroxidase included within a tyramide signal amplification kit (Invitrogen). Tyramide signal amplification–Alexa Fluor 488 or 594 was used to visualize antibody binding.

Image acquisition and quantification
Images were acquired using a Zeiss upright microscope (AxioImager
M1; Carl Zeiss, Oberkochen, Germany) at 20× magnification, and
analysis was carried out using the AxioVision Rel 4.8 software (Zeiss).
During image acquisition of EU-RNA and H3K9ac, careful consideration was taken to select an exposure that fell within the linear portion of the dynamic range of the camera to avoid overexposure.
EU-RNA– and H3K9ac-positive staining was determined by thresholding a lower-density cutoff, which was then maintained for all images analyzed. An integrated density value for each EU-RNA– and
H3K9ac-positive area was calculated using the formula
Integrated density = (Mean density × Area)
− (Background density × Area)
Densities across different exposure times were normalized, taking
into account the dark pixel intensity (Pang et al., 2012). EU-RNA–
and H3K9ac-positive nuclei were considered to be from myogenic
cells when a DAPI-positive nucleus fell inside the laminin stain of the
myofiber or nonmyogenic when the nucleus fell outside the laminin
border. Nuclei that did not contain an EU-RNA– or H3K9ac-positive
area were manually counted. Based on the results of the EU-RNA
experiments, H3K9ac quantification was restricted to myogenic
cells. For each animal, an average of 786 ± 37 and 609 ± 48 fibers
were analyzed per cross-sectional area for C57BL6/J and Pax7-DTA
mouse strains, respectively.

Cell-size global transcription analysis
Myofiber cross-sectional area was quantified on the same images
used for EU-RNA quantification. Cross-sectional area was determined
using automated segmentation of the myofiber by selecting an intensity threshold below that of the laminin fluorescent stain. For each
animal, an average of 509 ± 36 fibers per cross-sectional area were
analyzed. A relative fiber frequency based on cross-sectional area
was generated for each animal and averaged for each time point.
Based on the inherent variability between the cross-sectional area on
male and female mice, the cross-sectional area of male mice was
normalized using a correction factor (0.779) derived from a large
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cohort of control mice (n = 24 female and n = 24 male) from previous
studies (McCarthy et al., 2011; Fry et al., 2014) and unpublished data.
To determine the influence of cell size on transcriptional output,
data from the cross-sectional and EU-RNA analyses were aligned;
only myofibers that contained an EU-RNA–positive area were included in the analysis. If a single myofiber contained multiple EURNA labels (i.e., multiple nuclei), the data were summed to give a
total amount of EU-RNA for each fiber. About 200 myofibers were
quantified per animal, with each EU-RNA quantity normalized to the
geometric mean of all EU-RNA quantities. This was performed to
facilitate comparisons across animals with different overall labeling
intensities, since the primary objective was to determine how variation in cell size affected EU-RNA levels within each animal.

Nascent RNA affinity purification and cDNA synthesis
Total RNA was prepared from plantaris muscle using TRIzol reagent
(Invitrogen) according to the manufacturer’s directions. RNA samples
were treated with TURBO DNase (Ambion, Austin, TX) to remove
genomic DNA contamination. Total RNA concentration and purity
were assessed by measuring the optical density (230, 260, and
280 nm) with a Nanodrop 1000 Spectrophotometer (ThermoFisher
Scientific, Wilmington, DE). Nascent RNA was affinity purified from
4.5 μg of total RNA using the commercially available Click-iT Nascent
RNA Capture Kit (Life Technologies, Carlsbad, CA). cDNA was generated on 500 ng of total RNA and all EU affinity-purified RNA using
the SuperScript VILO cDNA Synthesis Kit (Life Technologies).

Cell type–specific transcript analysis
qPCR was performed using cDNA generated from both total and
nascent RNA. To minimize the effect of transcript half-life on the enrichment analysis, cell type–specific transcripts were selected based
on a narrow range of half-lives (Sharova et al., 2009). Short-lived transcripts had a half-life of 4-6.5 h, whereas intermediate-lived transcripts had a half-life of 16–18 h. Short-lived, cell type–specific transcripts included muscle RING-finger protein-1 (Murf1 or Trim63;
myofiber), paired box 7 (Pax7; satellite cell), epidermal growth factor-like module–containing mucin-like hormone receptor–like 1
(Emr1 or F4/80; macrophage), transcription factor 4 (Tcf4; fibroblast),
and endothelial-specific receptor tyrosine kinase (Tek or Tie2; endothelial cell). Intermediate-lived (16 to 18-h half-life) cell type–specific
transcripts included γ-sarcoglycan (Scgc; myofiber), colony-stimulating factor 2 receptor, α, low-affinity (granulocyte-macrophage)
(Csf2ra; macrophage), collagen, type III, α,1 (Col3a1; fibroblast) and
platelet/endothelial cell adhesion molecule 1 (CD31 or Pecam1; endothelial cell). The limited number and low expression of satellite
cell–specific genes precluded detection of an intermediate-lived
transcript for satellite cells. Cycle threshold (Ct) was determined using KiCqStart qPCR ReadyMix (KCQS07; Sigma-Aldrich) using 5 μl of
diluted cDNA (1/20 dilution from stock cDNA mixture). qPCR was
performed using an ABI 7900HT Fast RT-PCR system (Invitrogen),
and Ct was determined using ABI 7900HT Sequence Detection Systems software, version 2.3. Absolute quantification was achieved by
exponential conversion of the Ct using the qPCR efficiency, which
was estimated from standard curves obtained by serial dilutions
(one-log range) of a pooled sample for each RT set. Relative quantification for each transcript was determined using the relative
standard curve method, in which absolute values are generated for
both the transcript of interest and four stable transcripts (Rn7sk,
Gapdh, Tmx4, and Capzb) known to show little change in abundance in the synergist ablation model of skeletal muscle hypertrophy
(Chaillou et al., 2013). The geometric mean of the four stable transcripts was used to normalize the data (Vandesompele et al., 2002).
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Nascent RNA enrichment for each mRNA was determined by calculating its fold difference between nascent RNA and total RNA. Primers for all transcripts are listed in Supplemental Table S1.

Transcript stability assessment
Transcript stability was assessed by qPCR for myelocytomatosis oncogene (cMyc), myostatin (Mstn), F-box protein 32 (Mafbx, Fbxo32,
atrogin-1), and insulin-like growth factor 1 (Igf1). Transcript stability
was calculated as the ratio between the amounts of nascent RNA
and total RNA (nascent RNA:total RNA). All comparisons were made
relative to the sham condition ratio. A decrease in the nascent
RNA:total RNA ratio indicated that less mRNA was actively being
transcribed relative to the total RNA fraction, which was interpreted
as an increase in transcript stability. Conversely, an increase in the
nascent RNA:total RNA ratio indicated that more mRNA was actively being transcribed relative to the total RNA fraction, which was
interpreted as a decrease in transcript stability.

Statistical analyses
Data were analyzed using either a one-way or two-way analysis of
variance, followed by Tukey’s post hoc analysis to discriminate which
means differed. In cases of nonnormal distribution, data were log
transformed. For all analyses, significance was set at p < 0.05. Data
are presented as mean ± SEM.
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